“Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 mg in Patients of Chronic Heart Failure with Iron DeficiEncy - PRIDE-HF Study” (2023) Cardiology and Cardiovascular Medicine, 7(6), pp. 349–354. Available at: https://fortunejournals.org/ojs/index.php/ccm/article/view/16439 (Accessed: 17 September 2026).